CLINICAL EDUCATION HANDOUT CONTROL
Define Approved Patient Handout Masters
Identify the clinically approved patient handout before educators prepare revisions, translations or distribution copies.

01 / CONTEXT
Define the control decision
A health education team may hold drafts, clinically reviewed leaflets, accessible variants, translations and distribution copies. Record the authoritative master, topic, audience, owner, clinical approver and review date before applying restrictions.
Identify the clinically approved patient handout before educators prepare revisions, translations or distribution copies.
02 / PROCEDURE
Run the control sequence
- 01
Name the content owner and authorized clinical approver.
- 02
Record topic, audience, language, version and review date.
- 03
Separate drafts, translations and accessible variants from the approved master.
- 04
Test only with fictional conditions and non-operational contact details.
- 05
Publish revision, distribution and recovery owners.
03 / EVIDENCE
Preserve proof without personal data
A defensible control record identifies the handout owner, topic, intended audience, language, authoritative path, permitted accounts, restriction mode, version ID, clinical-review date, checksum evidence, recovery owner and next review date. It should not contain patient data, live contact details, credentials or unpublished clinical material. Use fictional conditions and non-operational contact details during every technical test.
Recheck the arrangement after changes to Windows, document software, accessibility tooling, translation workflow, storage, Folder Protect, permissions, service accounts or educator roles. Confirm both usability and recovery: an authorized educator should read the approved handout, an unauthorized account should not alter it, and the recovery owner should restore a separately held copy without depending on the protected folder. Preserve unexpected behavior before changing controls.
Keep the claim narrow. Local restrictions may reduce accidental writing, deletion or access on a tested Windows path, but they do not encrypt data, establish clinical accuracy, readability, accessibility, translation quality, medical approval or consent, administer identities, provide version history or replace backup. Escalate those requirements to the platform and accountable clinical owner designed to meet them.
Ask a second educator to follow the written procedure without verbal help. Record whether that person can identify the approved handout, create a working copy, recognize the version ID, interpret denied access and find the recovery owner. This usability check reveals ambiguous paths, hidden service-account dependencies and undocumented knowledge before a document, storage or staff change. Correct the procedure, repeat the test with fabricated data and retain only minimal evidence.
04 / BOUNDARY
State what the control cannot prove
A protected file does not establish clinical accuracy, informed consent, readability, accessibility, translation quality, medical approval or authorization to distribute.
Validate the exact Windows account, document application, handout workflow, storage path and current product release. If encryption, clinical approval, accessibility review, immutable history, identity governance or regulated retention are required, select systems designed for those jobs rather than broadening a desktop restriction claim.
05 / SOURCES
Primary references
References support specific controls and do not imply endorsement.